DOI QR코드

DOI QR Code

Development of Highly Sensitive Analytical Method for Evaluation of Evening Primrose Oil's Enhancing Effect in Prostaglandin E1(OP 1206) Biosynthesis

  • Lee, Sung-Hoon (Department of Pharmaceutical-Biomedical Engineering, College of Engineering, Cheongju University)
  • Received : 2018.12.03
  • Accepted : 2018.12.12
  • Published : 2018.12.31

Abstract

This study aimed to develop and validate highly sensitive determination method of a prostaglandin ($PGE_1$, OP 1206) in human plasma by LC-MS/MS using column switching. Plasma stored at $-30^{\circ}C$ and treated with methanol effectively inhibited interferences synthesized post-sampling. Samples were added with internal standard and were separated by reversed-phase HPLC with a cycle time of 30min. The method was selective for OP 1206 and the regression models, based on internal standard, were linear across the concentration range 0.5-50 pg/mL with the limit of quantification of 0.5 pg/mL (limit of quantitation, LOQ) for OP 1206. The calibration curve of OP 1206 standards spiked in five individual plasma samples was linear ($r^2=0.9999$). Accuracy and precision at the concentrations of 0.5, 1.5, 5.0 and 40 pg/mL, and at the lower LOQ of 0.5 pg/mL were excellent at 20%. OP120 < 6 was stable in plasma samples for at least 24 hours at room temperature, 24 hours frozen at $-70^{\circ}C$, 24 hours in an auto sampler at $6^{\circ}C$, and for two freeze/unfreezing cycles. The validated determination method successfully quantified the concentrations of OP 1206 in plasma samples from simulated administrating a single $5{\mu}g$ OP 1206 formulation. Thus, this novel LC-MS/MS technique for drug separation, detection and quantitation is expected to become the standard highly-sensitive detection method in bioanalysis and to be applied to many low dose pharmaceutical products.

Keywords

Acknowledgement

Supported by : Cheongju University

References

  1. Atikinson, H. C., I. Stanescu, C. Frampton, I.I. Salem, C.P. Beasley, and R. Robson. 2015. Pharmacokinetics and bioavailability of a fixed-dose combination of ibuprofen and paracetamol after intravenous and oral administration. Clin. Drug Investig. 35(10):625-632. DOI:10.1007/s40261-015-0320-8
  2. Food and Drug Administration. 2018. Guidance for industry, bioanalytical method validation. Silver Spring, MD: US Department of Health and Human Services. Center for Drug Evaluation and Research(CDER). Retrieved from https://www.fda.gov/downloads/drugs/guid ances/ucm070107.pdf
  3. Fujitani, B., M. Watanabe, J. Kuwashima, T. Tsuboi, T. Kadokawa, and T. Kitagawa. 1986. Effect of a prostaglandin E1 derivative (OP-1206) and acetylsalicylic acid on electrically induced thrombosis in guinea-pig mesenteric artery and its modification by an inhibitor of prostaglandin I2 synthetase, tranylcypromine. Jpn. J. Pharmacol. 40(1):31-35. DOI:10.1254/jjp.40.31
  4. Inoue, Y., N. Sekiya, K. Katayama, S. Narutaki, M. Yamamoto, D. Iohara, F Hirayama, and K. Uekama. 2014. Stabilizing effect of ${\beta}$-Cyclodextrin on Limaprost, a PGE1 Derivative, in Limaprost Alfadex Tablets (Opalmon(R)) in highly humid conditions. Chem. Pharm. Bull. 62(8):786-792. DOI:10.1248/cpb.c14-00150
  5. Komaba, J., Y. Masuda, Y. Hashimoto, S. Nago, M, Takamoto, K. Shibakawa, S. Nakade, and Y. Miyata. 2007. Ultra sensitive determination of limaprost, a prostaglandin E1 analogue, in human plasma using on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 852:590-597. DOI:10.1016/j.jchromb.2007.02.031
  6. Lee, K.J., H.J. Yang, and J.Y. Ma. 2014. Simultaneous analysis of 12 kind maker components in Banhabaekchulchhonmatang by RP-HPLC. J. Korea Acad. Ind. Coop. Soc. 15(7):4682-4691. DOI:10.5762/KAIS.2014.15.7.4682
  7. Malone, J. and L. Hughes. 2014. An HPLC-MS/MS method for the determination of oxycodone, noroxycodone & oxymorphone in human plasma. Craigavon, United Kingdom: Almac Sciences. DOI:10.13140/RG.2.1.5059.0242
  8. Omran, O.M. 2012. Histopathological study of evening primrose oil effects on experimental diabetic neuropathy. Ultrastruct. Pathol. 36(4):222-227. DOI:10.3109/01913123.2012.662268
  9. Rodgers, A., S. Lewandoski, S. Allie-Hamdulay, D. Pinnock, G. Baretta, and G. Gambaro. 2009. Evening primrose oil supplementation increases citraturia and decreases other urinary risk factors for calcium oxalate urolithiasis. J. Urol. 182(6):2957-2963. DOI:10.1016/j.juro.2009.08.021
  10. Steuer, A.E., A.M. Forss, A.M. Dally, and T. Kraemer. 2014. Method development and validation for simultaneous quantification of 15 drugs of abuse and prescription drugs and 7 of their metabolites in whole blood relevant in the context of driving under the influence of drugs-Usefulness of multi-analyte calibration. Forensic Sci. Int. 244:92-101. DOI: 10.1016/j.forsciint.2014.08.022
  11. Swainston Harrison, T., and G.L. Plosker. 2007. Limaprost. Drugs 67(1):109-118. DOI:10.2165/00003495-200767010-00010
  12. Tsuboi, T., B. Fujitani, J. Maeda, K. Yoshida, M. Shimizu, A. Kawasaki, T. Okegawa, and M. Tsuboshima. 1980. Effect of OP-1206, a prostaglandin E1 derivative, on guinea-pig platelet functions. Thromb. Res. 15(5-6):573-580. DOI: 10.101 6/0049-3848(80)90145-0 https://doi.org/10.1016/0049-3848(80)90145-0
  13. Wettasinghe, M., F. Shahidi, and R. Amarowicz. 2002. Identification and quantification of low molecular weight phenolic antioxidants in seeds of evening primrose (Oenothera biennis L.). J. Agric. Food Chem. 50(5):1267-1271. DOI: 10.102 1/jf010526i https://doi.org/10.1021/jf010526i
  14. Zimmerman, D.C., and P. Feng. 1978. Characterization of a prostaglandin-like metabolite of linolenic acid produced by a flaxseed extract. Lipids 13(5): 313-316. DOI:10.1007/BF02533720